Shares of Agios Pharmaceuticals (AGIO) traded higher in the premarket on Tuesday after the U.S. FDA granted priority review for its marketing application seeking a label expansion for its lead product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results